CX11, a daily oral pill, showed up to 11.5% weight loss at 36 weeks in phase 2. The money is meant to carry it through global phase 3.
Recap by typeshit. Full story at BioXconomy.
An investing platform's company history runs from Lilly's 1876 founding through Humulin and Prozac to its obesity drug boom. Background, not news.
Generic advice that a lack of hunger doesn't mean you've eaten enough, with a nudge toward smaller portions built around protein.
Dr. Mimi Tan points to a wider set of obesity treatments and notes Ozempic is the semaglutide brand meant for type 2 diabetes.
Brian Underwood shares that the Men's Health fall issue starring Drake Maye is on newsstands, with peptides among the topics inside.
Bikman cites a four-week trial in young men eating about 40% under their needs, where the high-protein group added lean mass and shed more fat.
Meta-analyses show four to six times more retained stomach contents in users, and guidance is moving from blanket pauses toward case-by-case plans.
Loading…